Navigation Links
Nvision Biomedical Technologies Launches Pedicle Screw System at NASS
Date:9/27/2018

Nvision Biomedical Technologies, a San Antonio-based medical device and biologics manufacturer, debuted its focus® Pedicle Screw System today at the North American Spine Society (NASS) Annual Meeting, held at the Los Angeles Convention Center, September 26-29.

The Nvision focus Pedicle Screw System, which received clearance from the U.S. Food and Drug Administration (FDA) in April, keeps patient safety in mind by focusing on ease and flexibility of use by surgeons. The system offers both minimally invasive and open surgery options with standard double lead thread and midline cortical thread options.

The midline cortical thread has a fast-starting initial thread, which is ergonomically designed and allows the surgeon to move faster in surgery. Additionally, the cortical option provides surgeons the flexibility to utilize a midline approach and not just a pedicle approach. For minimally invasive procedures, surgeons have an option to use a tower attachment or an extended tulip design with break-away tabs. This innovative technology allows for common instruments across procedures giving surgeons a choice without having to worry about specific instrumentation per system. Additionally, focus provides benefits for the hospital and surgical support team as well by streamlining implant delivery; minimizing tray space and limiting the number of instruments.

“As we expand our product portfolio at Nvision, our goal is to create devices and instrumentation that address industry challenges and provide solutions for surgeons,” said Tom Zink, Nvision Senior Vice President of Product Development. The focus Pedicle Screw System was developed through collaboration with surgeons to make their concept of the optimum pedicle screw system a reality.

The focus Pedicle Screw System, which will be available to surgeons in December, is Nvision’s latest product to enter the market. The company, which was founded in 2013, has several products in the marketplace including four interbody fusion systems ¬– the nv line, one anterior cervical plate system – the tangis® line, and a buttress plate system – the boundary® line. The interbody devices have multiple footprints to adapt to the general shape of the vertebral endplates. Each set is available in a variety of heights to accommodate patient variability. Additionally, Nvision offers products with Structural Encoding®, the industry’s most innovative solution for medical device identification with permanent direct part marking, as well as a portfolio of human tissue allograft products including celera birth tissue patches and fluids as well as forma musculoskeletal bone and sports medicine grafts.

About Nvision Biomedical Technologies
Nvision is a San Antonio-based medical device and biologics manufacturing company focused on providing surgeons implants that are paired with instrumentation and biologics to simplify and improve surgery procedures that help patients get back to their quality of life.

Nvision is committed to developing and manufacturing thoughtfully designed products combined with exceptional service that keep the patients, surgeons, healthcare providers and distribution partners in mind. Nvision aligns with surgeon thought leaders, key researchers, and development engineers from prestigious institutions to design, test, and bring to market the most innovative concepts.

Read the full story at https://www.prweb.com/releases/nvision_biomedical_technologies_launches_pedicle_screw_system_at_nass/prweb15791627.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Inivata Highlights its InVisionTM ctDNA Assay for Broad Molecular Profiling and Presentation of NSCLC data at ASCO Annual Meeting 2016
2. American Association of Colleges of Nursing honors Fairfield University’s School of Nursing for Re-envisioning Nursing Education
3. Brian Pogue Named Editor of Journal of Biomedical Optics
4. SPIE Partners with Four Biomedical Optics Labs on New Postdoc Fellowship
5. Slone Partners Fills VP of Scientific Affairs Role for Cambridge Biomedical
6. Global dPCR Market to Grow at a CAGR of 10% by 2021 - Rapid Growth of the Biomedical Sector in APAC is Likely to Boost the Adoption of PCR Solutions - Research and Markets
7. Amarantus Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.
8. Boston Biomedical Celebrates 10-Year Anniversary of its Founding and Announces Appointment of Patricia S. Andrews as Chief Executive Officer
9. Emmaus Life Sciences, Inc. to Present at Los Angeles Biomedical Research Institutes (LA BioMed) Innovation Showcase
10. Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI Symposium
11. Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... ... 2018 , ... Shell’s Puget Sound Refinery recently presented the ... high-tech machine that turns plastic into prosthesis. The Million Waves Project collects and ... the usable plastic and turns it into 3D printed prosthetic limbs for children ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the ... Bio-Energy) AssurEOR product line was chosen for its advancements in the production chemicals ... leading innovations in upstream oil applications that are positively impacting the industry. The ...
(Date:9/28/2018)... ... 2018 , ... GlycoMark®, Inc. has announced a partnership with ... the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions ... GlycoMark test to its network of physicians through its sales organization and MD ...
(Date:9/27/2018)... ... September 26, 2018 , ... Medable was named DPharm ... build the first human digitome, a digital representation of human health and disease, ... integration of all data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, ...
Breaking Biology Technology:
(Date:10/5/2018)... ... October 04, 2018 , ... CallTower Inc., ... present at Microsoft Ignite 2018, in Orlando, Florida, when Microsoft made a major ... statement about the new direction of Skype for Business Online, outlining the following ...
(Date:10/5/2018)... (PRWEB) , ... October 04, 2018 , ... High dose ... some of the tests such as cardiac troponin has serious clinical complications. There is ... the exact prevalence is still unknown. , High dose of biotin supplement use ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... development and commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a ... type 2 diabetes and progressive diabetic kidney disease in a four-site, pan-European ...
Breaking Biology News(10 mins):